News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Cardiovascular disease
Starting HIV treatment with a CD4 cell count below 350 associated with a key marker of cardiovascular risk

Starting HIV treatment with a CD4 cell count below 350 cells/mm3 may increase the long-term risk of cardiovascular disease, US research published in AIDS suggests. Investigators found

Published
25 May 2012
By
Michael Carter
Adherence
HIV treatment breaks lead to drug resistance in the female genital tract

Antiretroviral treatment interruptions of 48 hours or more are associated with the emergence of resistant strains of HIV in the female genital tract, investigators report in the

Published
24 May 2012
By
Michael Carter
Drug interactions and pharmacokinetics
13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona

This important annual workshop always includes studies that are not presented to other meetings.

Published
23 May 2012
From
i-base
Resistance
UGANDA: Rising ARV resistance threatens HIV fight

The prevalence of drug-resistant HIV strains in Uganda has risen from 8.6 percent to 12 percent in the last five years, one of the highest rates in Sub-Saharan Africa, according to a recent study.

Published
22 May 2012
From
IRIN Plus News
New and experimental treatments
Broad-Spectrum Antivirals: The Future of HIV Treatment?

Could a single drug be used to treat a variety of viruses -- potentially all viruses, including HIV? At least three novel approaches are being worked on to create such a drug, also known as a broad-spectrum antiviral.

Published
17 May 2012
From
The Body
Cardiovascular disease
Doubt Cast on the ‘Good’ in ‘Good Cholesterol’

A study in the Lancet that makes use of powerful databases of genetic information has found that raising the levels of high-density lipoprotein HDL, the so-called 'good' cholesterol, may not reduce heart disease risk as was thought.

Published
17 May 2012
From
New York Times
Transmission and prevention
Slim Abdool Karim: Shaking up SA’s ailing medical research

Hand-picked for the job by Health Minister Aaron Motsoaledi, Karim is used to difficult challenges. He was a political activist and medical student at the height of apartheid and went on to become one of the world’s leading HIV researchers, investigating vaginal gels to protect women from infection.

Published
11 May 2012
From
Business Day
Adherence
Canadian cohort shows viral suppression most likely with atazanavir/ritonavir-based HIV treatment after 6 months

Antiretroviral therapy based on the ritonavir-boosted protease inhibitor atazanavir (Reyataz) was more likely to achieve virological suppression after six months than treatment containing the non-nucleoside reverse transcriptase inhibitor

Published
11 May 2012
By
Michael Carter
Adherence
Black race and depression associated with poorer adherence to HIV treatment

African American patients have significantly poorer adherence to HIV therapy compared to other racial groups, investigators report in Journal of General Internal Medicine. Overall, black patients were 30%

Published
08 May 2012
By
Michael Carter
Outcomes and prognosis
Co-infection with hepatitis C increases mortality risk by 50% for patients with AIDS

Co-infection with hepatitis C increases the risk of death for patients with AIDS by 50%, according to the results of a large study published in the online

Published
06 May 2012
By
Michael Carter
← First12345...71Next →

Filter by country